Thomas Sell - Concepedia

Author

Thomas Sell

Charité - Universitätsmedizin Berlin ORCID

Also Known As

Sell, Thomas, Thomas S. Sell, Thomas Sell

Publications

526

Citations

H-Index

Concepts

All Affiliations

Charité - Universitätsmedizin Berlin Heidelberg University Humboldt-Universität zu Berlin German Cancer Research Center Freie Universität Berlin

About

Thomas Sell is an author at Charité - Universitätsmedizin Berlin specializing in colorectal cancer, tumor biology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	301
2	Cell Biology	3	3	301
3	Immunology	1	1	15
4	Cancer Cell Biology	1	1	189
5	Cancer Therapeutics	1	1	15

Thomas Sell

Publications

524

Citations

H-Index

Page 1

	Year	Citations
Mitogen‐activated protein kinase activity drives cell trajectories in colorectal cancer Florian Uhlitz, Philip Bischoff, Stefan Peidli, EMBO Molecular Medicine Cancer ResearchSignaling PathwayCell RegulationMedicineColorectal Cancer	2021	189
Cell type-dependent differential activation of ERK by oncogenic KRAS in colon cancer and intestinal epithelium Raphael Brandt, Thomas Sell, Mareen Lüthen, Nature Communications Oncogenic KrasSignal TransductionSignaling PathwayOncogenic AgentReceptor Tyrosine Kinase	2019	97
Protonophore properties of hyperforin are essential for its pharmacological activity Thomas Sell, Thabet Belkacemi, Veit Flockerzi, Scientific Reports	2014	59
Conserved Gating Elements in TRPC4 and TRPC5 Channels Andreas Beck, Tilman Speicher, Christof Stoerger, Journal of Biological Chemistry	2013	54
Helicobacter pylori shows tropism to gastric differentiated pit cells dependent on urea chemotaxis Carmen Aguilar, Mindaugas Paužuolis, Malvika Pompaiah, Nature Communications	2022	46
SFPQ Depletion Is Synthetically Lethal with BRAFV600E in Colorectal Cancer Cells Kathleen Klotz‐Noack, Bertram Klinger, Maria Rivera, Cell Reports	2020	34
Mitogen-activated protein kinase activity drives cell trajectories in colorectal cancer Florian Uhlitz, Philip Bischoff, Stefan Peidli,	2020	15
Triple Targeting of HER Receptors Overcomes Heregulin-mediated Resistance to EGFR Blockade in Colorectal Cancer Alexander Rau, Nicole Janssen, Lennart Kühl, Molecular Cancer Therapeutics ImmunologyImmunotherapeuticsKras Wt DiseaseImmunotherapyCancer Biology	2022	15
Oncogenic signaling is coupled to colorectal cancer cell differentiation state Thomas Sell, Christian Klotz, Matthias M. Fischer, The Journal of Cell Biology	2023	15

Page 1